Current and future use of favipiravir in patients with COVID-19
There are experimental and clinical data regarding the activity of favipiravir against the SARS-CoV-2 virus. The is evidence of significant variability in pharmacokinetics and associated achievement of the required inhibitory concentration of the drug. The evidence base for the effectiveness of use...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
Izdatelstvo OKI
2020-10-01
|
| Serie: | Качественная клиническая практика |
| Soggetti: | |
| Accesso online: | https://www.clinvest.ru/jour/article/view/540 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|